分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

miR‑124‑3p acts as a potential marker and suppresses tumor growth in gastric cancer

Feng Liu, Hongjuan Hu, Jianfu Zhao, Zhiwei Zhang, Xiaohong Ai, Liyun Tang, Liming Xie

Journal:Biomedical Reports

IF:0

DOI:10.3892/br.2018.1113

PMID:

Published:2018-06-20

research field:肿瘤学分子生物学癌症遗传学

Abstract

miR-124-3p has been implicated in a variety of cancers. The purpose of the present study was to investigate the expression, prognostic roles and functions of miR-124-3p in gastric cancer. Functional studies indicated that ectopic overexpression of miR-124-3p in gastric cancer cells suppressed cell viability and plate colony formation in vitro and tumor growth in vivo. In situ hybridization analysis demonstrated that decreased expression of miR-124-3p was associated with clinical stage and lymph node metastasis, as well as shorter overall survival and disease-free survival rates. Furthermore, it was observed that miR-124-3p repressed the carcinogenesis of gastric cancer by targeting Ras-related C3 botulinum toxin substrate 1 (Rac1) and specificity protein 1 (SP1). Collectively, these results indicate a potential underlying mechanism for the regulation of gastric cancer by miR-124-3p involving targeting of Rac1 and SP1. Thus, miR-124-3p may be an independent indicator of survival and treatment strategy for patients with gastric cancer.

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用